Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector
The PRIP Scheme is implemented by the Department of Pharmaceuticals , under the Ministry of Chemicals and Fertilizers, Government of India. The purpose of the scheme is to strengthen research and innovation in the Indian pharma & medical-technology sector transforming from a cost/volume-model to an innovation-based growth model, encouraging industry-academia linkages, and boosting global competitiveness. It is targeted at projects spanning from early-stage research to later-stage commercialisation . According to the public release, about ₹5,000 crore has been approved outlay, expected to co-catalyse around ₹11,000 crore of R&D investment across roughly 300 projects.
Key Features
- Two components: Component A & B: Under Component A the scheme sets up Centres of Excellence at the existing national institutes (e.g., the seven National Institute of Pharmaceutical Education and Research ) to build research capacity in identified priority areas. Under Component B, the focus is on supporting industry, MSMEs, startups and academia to undertake defined R&D projects from idea to commercialisation.
- Support for early-stage / later-stage projects: For early stage projects there is higher relative assistance; for later stage larger cost projects there is support up to a defined cap.
- Focus on strategic public-health innovation areas : The scheme designates certain areas where greater support is available (for later stage up to 50% of cost) given their societal importance though possibly lower commercial incentive.
- Industry–Academia collaboration and in-licensing: The scheme encourages that industry/ startups collaborate with accredited academic & research institutions, or in-license IP from academia, strengthening translational linkages. For example, preference in selection is given to such collaborations.
- Digital innovation ecosystem & CoEs: The scheme envisages establishment of digital innovation exchange platform, linking innovators, investors, mentors, and global opportunities; also infrastructure strengthening through CoEs at NIPERs.
Financial Assistance
Eligibility Criteria
Who Can Apply:
- Indian-incorporated entities: companies in the pharma/MedTech space, MSMEs, and startups registered in India.
- Projects located in India . Projects must be in the defined priority areas .
- Applicants must meet specified Technology Readiness Level criteria relevant to project category as per scheme guidelines.
- Entities seeking assistance must prepare a detailed project plan/proposal, comply with scheme terms and submit through the portal.
Who Cannot Apply:
- Unincorporated individuals or unregistered teams: only registered entities are eligible.
- Projects purely outside human-health/MedTech domain are not covered.
- Projects that don’t meet minimum eligibility criteria in terms of TRL, prior R&D spend or documentation may be rejected
Documents Required
- Entity registration proof
- Project proposal / Detailed Project Report covering scope, innovation, TRL status, budget, timeline, commercialisation plan
- Financial statements , prior R&D spend
- Collaboration agreement (if industry–academia partnership)
- Intellectual Property status/strategy documentation
- Benefit-sharing plan as required by scheme
- Compliance certifications and any required import/export or device certifications
- Milestone plan and monitoring framework
Application Process for the Scheme
Option 1: Apply with Bullit
Click here to start with guided support. Our team verifies eligibility, compiles documents, and handles application & follow-ups on your behalf. You can monitor progress while focusing on operations.
Recommended for: Start-ups, MSMEs or companies in pharma/MedTech looking for clarity and assistance in navigating the PRIP scheme.
Option 2: Direct Government/Agency Process
- Visit the official PRIP portal of the Department of Pharmaceuticals.
- Register your entity and prepare your detailed project proposal aligned with one of the priority areas under the scheme.
- Submit online application during the open call window; follow instructions, upload required documents, and respond to subsequent queries.
- Undergo evaluation ; on approval, sign grant/assistance agreement; implement project and comply with monitoring/milestones.
Option 3: Apply Through the Official Online Portal
Applicants can submit their applications directly through the official PRIP web portal. The process involves completing the online application form, uploading all required documents, and submitting digitally for review. After submission, the Department of Pharmaceuticals or its Project Management Agency verifies the details and communicates next steps or approval status. This option suits organisations comfortable managing the process independently through the official online system.